Scarica l'app Stockscreener
29.00
0.21%
-0.06
Dopo l'orario di chiusura:
27.81
-1.19
-4.10%
Vor Biopharma Inc Borsa (VOR) Ultime notizie
Vor Biopharma (VOR) shareholder reprogrammed interchange sells $2.35 million in stock - Investing.com
Vor Biopharma (VOR) shares sold by RA Capital for $13.7 million - Investing.com Australia
Vor Bio Announces Late-Breaking Oral Presentation of China - GlobeNewswire
Can machine learning forecast Vor Biopharma Inc. recoveryWeekly Investment Summary & Community Consensus Stock Picks - newser.com
Can Vor Biopharma Inc. stock maintain operating marginsJuly 2025 Closing Moves & Advanced Swing Trade Entry Alerts - newser.com
Vor Bio (VOR) Shares Positive Phase 3 Study Results for Telitaci - GuruFocus
Can Vor Biopharma Inc. stock resist sector downturnsPortfolio Update Summary & Free Risk Controlled Daily Trade Plans - newser.com
Vor Biopharma (VOR) 10% owners sell shares worth $3 million By Investing.com - Investing.com Nigeria
Vor Biopharma (VOR) 10% owners sell shares worth $3 million - Investing.com India
Reid Hoffman-linked entity reports VOR sales; 1,278,118 shares held - Stock Titan
Baird Upgrades Vor Biopharma (VOR) - Nasdaq
Baird Upgrades Vor Biopharma to Outperform From Neutral, Adjusts Price Target to $64 From $20 - MarketScreener
Vor Biopharma's Telitacicept: A Pipeline In Itself? - RTTNews
VOR Biopharma (VOR) Receives Significant Analyst Upgrade from Ba - GuruFocus
Baird upgrades Vor Biopharma stock rating to Outperform on telitacicept potential - Investing.com
Baird Upgrades Vor Biopharma, Inc. (VOR) to Outperform - StreetInsider
Combining price and volume data for Vor Biopharma Inc.Weekly Investment Summary & AI Optimized Trading Strategy Guides - newser.com
Vor Bio's Collaborator Delivers Positive Results For Telitacicept In Autoimmune Disorder That Impacts Tears - Benzinga
Vor Biopharma stock rises after positive Phase 3 results for Sjögren’s treatment By Investing.com - Investing.com South Africa
Vor Biopharma stock rises after positive Phase 3 results for Sjögren’s treatment - Investing.com Australia
Vor Bio rises after partner RemeGen succeeds in Sjögren’s disease study - Seeking Alpha
Vor Bio (VOR) and RemeGen Report Strong Phase 3 Results for Teli - GuruFocus
Vor Biopharma Inc. (NASDAQ:VOR) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Reprogrammed Interchange Llc Sells 48,884 Shares of Vor Biopharma (NASDAQ:VOR) Stock - MarketBeat
Vor Biopharma (NASDAQ:VOR) Major Shareholder Sells $2,549,123.94 in Stock - MarketBeat
Vor Biopharma Inc.'s (NASDAQ:VOR) Intrinsic Value Is Potentially 55% Above Its Share Price - simplywall.st
Vor Biopharma (VOR) 10% owner sells $4.1 million in stock By Investing.com - Investing.com Australia
Vor Biopharma (VOR) 10% owner sells $4.1 million in stock - Investing.com
Reid Hoffman-linked entity disposes of 124,146 VOR shares at $31.92–$34.34 - Stock Titan
Is Vor Biopharma Inc. stock poised for growth2025 Key Highlights & High Return Stock Watch Alerts - newser.com
Reversal indicators forming on Vor Biopharma Inc. stock2025 Buyback Activity & Verified Short-Term Trading Plans - newser.com
What indicators show strength in Vor Biopharma Inc.Portfolio Performance Summary & Weekly High Potential Stock Alerts - newser.com
What analyst consensus says on Vor Biopharma Inc. stock2025 Retail Activity & Free Daily Entry Point Trade Alerts - newser.com
Is Vor Biopharma Inc. meeting your algorithmic filter criteria2025 Historical Comparison & Expert Verified Stock Movement Alerts - newser.com
Vor Biopharma's (VOR) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Vor Biopharma (NASDAQ:VOR) Major Shareholder Reprogrammed Interchange Llc Sells 70,763 Shares - MarketBeat
Vor biopharma $3.5m stock sale by ten percent owner - Investing.com Australia
Vor Biopharma Inc. (VOR) stock price, news, quote and history - Yahoo
Relative strength of Vor Biopharma Inc. in sector analysisJuly 2025 Trade Ideas & Free Technical Confirmation Trade Alerts - newser.com
Published on: 2025-10-09 02:38:01 - newser.com
Vor biopharma $3.5m stock sale by ten percent owner By Investing.com - Investing.com Australia
VOR: Reporting persons disclose open-market sales and 21.9% ownership - Stock Titan
Reid Hoffman/Form 4 reports 98,387 VOR shares sold, 1.50M held - Stock Titan
Can momentum traders help lift Vor Biopharma Inc.Dividend Hike & Low Risk Investment Opportunities - newser.com
1.84%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):